【レポートの概要（一部）】
1. Report Overview
1.1 Global Generic Drugs: Market Overview
1.2 Global Generic Drugs Market Segmentation
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Key Questions Answered By This Analytical Report
1.6 Who Is This Report For?
1.7 Methodology
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2. An Introduction to Generic Drugs
2.1 An Introduction to the Rise of Generic Drugs
2.2 What Are Generic Drugs?
2.2.1 Generic Active Ingredients
2.3 A Brief Overview of the Pharmaceutical Industry
2.3.1 Brief History of Generic Drugs
2.3.2 The Hatch-Waxman Act: The Rise of Generics
2.4 Demonstrating Bioequivalence: A Major Factor in Approving Generics
2.5 Types of Generics – Authorised, Branded and Unbranded
2.6 Complex Generics
2.7 Classification of Generic Drugs Markets
2.8 Is Generic Substitution Bad News for Big Pharma Business?
2.8.1 The ‘Evergreening’ of Pharmaceutical Products
2.9 Regulation of Generic Drugs
2.9.1 Regulation in the US
2.9.2 Regulation in Europe
2.9.3 Regulation in Japan
2.9.4 Regulation in China
2.10 Compulsory Licensing
2.11 Market Definition and Scope of This Report
2.11.1 Market Sizing and Revenue Reporting
2.11.2 Currency Exchange Rates in This Report
3. Generic Drugs Market 2016-2026
3.1 The Global Generic Drugs Market: Market Overview
3.1.1 Segmenting the Global Generic Drugs Market
3.2 The Rise of the Global Generic Drugs Market in 2015
3.3 Changes in the Regional Distribution of the Generic Drugs Market 2014-2015
3.4 The Global Generic Drugs Market: Sales Forecast 2016-2026
3.5 Generic Drugs: Regional Market Forecast: 2016-2026
3.5.1 Changes in Generic Drug Regional Market Shares 2016-2026
3.6 Leading National Markets for Generic Drugs: Market Forecast 2016-2026
3.7 National Markets that will Drive Generic Drugs Growth
3.8 Changes in Market Shares by National Market 2016-2026
3.9 Drivers and Restraints for the Global Generic Drugs Market 2016-2026
4. US Generic Drugs Market, 2016-2026
4.1 Generic Drugs in the US: Market Overview
4.1.1 The Effects of Generics on Healthcare Spending in the US
4.1.2 The Hatch-Waxman Act and Its Ongoing Effects
4.1.3 Consolidation in the Drug Development and Supply Chain Driving US Generics
4.2 US Historical Generic Penetration Rates
4.3 Leading Companies Operating within the US Generic Drugs Market
4.3.1 The Increasing Acceptance of Generics amongst Consumers
4.3.2 Affordable Care Act: Expanding Medicare Coverage
4.4 The US Generic Drugs Market: Drivers and Restraints 2016-2026
4.5 The US Generic Drugs Market Forecast: 2016-2026
4.6 The US Generic Drugs Market – Strategic Analysis
4.6.1 Will Biosimilars Dictate the Future of the US Generics Market?
4.6.2 The Backlog of ANDA Applications
4.6.3 The Generic Drug User Fee Amendments (GDUFA)
4.6.4 Shortages of Generic Drugs Will Restrain the Market
4.6.5 The Anti-Competitive ‘Pay for Delay’ Effect
4.7 US Generic Drugs Market: A Range of Factors Contributing to Growth
5. Leading European Generic Drug Market, 2016-2026
5.1 European Generic Drugs: Market Overview
5.1.1 The EU5
5.1.2 Why Growth in Some Markets is Being Hindered?
5.1.3 Predominant Pricing Systems and Generic Penetration In European Markets
5.1.4 Will Europe Move towards Free-Pricing Systems?
5.1.5 Challenges in the European Regulatory Environment
5.1.6 Ending Anti-Competitive ‘Pay for Delay’ Tactics in Europe
5.1.7 FDA and EMA Joint Data Sharing and Inspections
5.2 EU5 Generic Drugs Market Forecast: 2016-2026
5.3 EU5 Market Share Breakdown 2016-2026
5.4 Germany: New Reforms to Medicinal Pricing May Impact Market Entry
5.4.1 German Generic Drugs Market: Generic Penetration By Volume, 2000-2015
5.4.2 German Generic Drugs Market: Generic Penetration by Value, 2000-2015
5.5 UK Generic Drugs Market: A Mature Market with Growth Potentials
5.5.1 UK Generic Drugs Market: Sales Forecast 2016-2026
5.5.2 Cost Pressures and Demand-Side Policies Drive UK Generic Penetration
5.5.3 UK Generic Drugs Market: Generic Penetration by Volume, 2000-2015
5.5.4 UK Generic Drugs Market: Generic Penetration by Value, 2000-2015
5.5.5 Pharmacists as Enforcers of Generic Substitution
5.5.6 Pay Time for ‘Pay-For-Delay’
5.5.7 GSK: Widening the Gate to Accessible Medicines
5.6 French Generic Drugs Market: Healthcare Reforms Impacting on Market Growth
5.6.1 French Generic Drugs Market: Sales Forecast 2016-2026
5.6.2 French Generic Drugs Market: Generic Penetration by Volume, 2000-2015
5.6.3 French Generic Drugs Market: Generic Penetration by Value, 2000-2015
5.7 Italian Generic Drugs Market: Branded Generics Hindering Overall Growth
5.7.1 The Tightening of Italy’s Patent Legislations
5.7.2 The Italian Healthcare System – A Tale of Falling Budgets
5.7.3 Italian Generic Drugs Market: Sales Forecast: 2016-2026
5.7.4 Italian Generic Drugs market: Generic Penetration by Volume
5.7.5 Italian Generic Drugs Market: Generic Penetration by Value
5.8 Spain
5.8.1 Cost-Containment Measures Helping to Boost Generic Drug Use
5.8.2 Spanish Generic Drugs Market: Sales Forecast 2016-2026
5.8.3 Spanish Generic Drugs Market: Generic Penetration by Volume, 2000-2015
5.8.4 Spanish Generic Drugs Market: Generic Penetration by Value, 2000-2015
6. Asia-Pacific Generic Drugs Market, 2016-2026
6.1 Generic Drugs in the Asia-Pacific Market: Market Overview
6.2 Chinese Generic Drugs Market: Domestic Companies Dominate the Market Landscape
6.2.1 The Major Drivers of Growth in the Chinese Generics Market
6.2.2 Chinese Generic Drugs Market: Sales Forecast 2016-2026
6.2.3 Compulsory Licensing of Generic Drugs
6.2.4 Expansion of Healthcare Coverage and Reimbursement
6.2.5 Chinese Generic Drugs Market: Generic Penetration by Volume, 2000–2015
6.2.6 Chinese Generic Drugs Market: Generic Penetration by Value, 2000-2015
6.2.7 The Impacts of Price Controls and the Anhui Model
6.3 Japanese Generic Drugs Market: High Barriers to Entry
6.3.1 Public Perception of Generics in Japan
6.3.2 Japanese Generic Drugs Market: Leading Companies
6.3.3 Japanese Generic Drugs Market: Sales Forecast 2016-2026
6.3.4 Japanese Generic Drugs Market: Generic Penetration by Volume, 2000–2015
6.3.5 Japanese Generic Drugs Market: Generic Penetration by Value, 2000-2015
6.3.6 Government Initiatives Driving Generic Penetration
6.3.7 Japanese Attitudes to Generic Drugs
6.4 Indian Generic Drugs Market: Regulatory Failures Hindering Sales Growth
6.4.1 Leading Companies in the Indian Generic Drugs Market
6.4.2 Indian Generic Drugs Market: Sales Forecast 2016-2026
6.4.3 The Reforms to India’s Drug Prices Control Order and Its Likely Effects on Generic Drugs Revenues
6.4.4 Expansion of the National Healthcare Coverage Increases the Need for Generics
6.4.5 Has Recent Manufacturing Quality Failures Dented India’s Generics Growth?
7. Emerging Generic Drugs Market, 2016-2026
7.1 Generic Drugs in the Emerging Market: Market Overview
7.1.1 Emerging Economies: Improving Logistics and Better Infrastructure Catalysing Generics Growth
7.2 Brazil
7.2.1 Brazilian Generic Drugs Market: Sales Forecast 2016-2026
7.2.2 Generics to Facilitate Low-Income Earner’s Access to Medicines
7.2.3 Foreign Generic Drug Manufacturers Entering the Brazilian Market
7.3 Russian Generic Drugs Market: Improving IP Protection to Aid Market Growth
7.3.1 Historical Trends in Russia’s Pharmaceutical Production and Distribution
7.3.2 The Pharma2020 Strategy – Healthcare and Industry Reform
7.3.3 Self-Medication in Russia and the Integral Role of Pharmacies
7.3.4 Russian Generic Drugs Market: Sales Forecast 2016-2026
7.4 Mexico
7.4.1 Government Programmes to Vitalise Generic Penetration in Mexico
7.4.2 Regulatory Changes and the Inception of COFEPRIS
7.4.3 Mexican Generic Drugs Market: Sales Forecast 2016-2026
7.5 South Korea
7.5.1 Pharmaceutical Price Controls and Measures Being Implemented in South Korea
7.5.2 South Korean Generic Drugs Market: Sales Forecast 2016-2026
7.6 Turkey
7.6.1 Cost Cutting Measures and their Effects on Turkish Generics
7.6.2 Will Turkey Become a Production Base for High Technology Products?
7.6.3 Turkish Generic Drugs Market: Sales Forecast 2016-2026
7.6.4 Regulatory Guidelines for Generic Drugs in Turkey
7.6.5 How Effective has Turkey’s Health Transformation Programme Been?
8. Leading Companies in the Generic Drugs market, 2016-2026
8.1 Generic Drugs: Continuous Expansion to Rival
8.1.1 The Leading Companies in the Global Generics Market
8.2 Teva
8.2.1 Teva: Historical Financial and Performance Analysis, 2010-2014
8.2.2 Teva Generic Drugs Sales Forecast 2016-2026
8.2.3 Teva and Allergan Spin-Off Generic Drug Deal
8.2.4 Allergan: Historical Financial and Performance Analysis, 2010-2014
8.2.5 Allergan: Developments in Generic Drug Segment Prior Mega-Deal
8.2.6 Teva: Generic Drugs Portfolio Analysis, 2016
8.2.7 Teva: What Future Moves Could We Expect?
8.3 Novartis
8.3.1 Novartis: Historical Financial and Performance Analysis, 2010-2014
8.3.2 Novartis Generic Drugs Sales Forecast 2016-2026
8.3.3 Novartis Generic Drugs Portfolio Analysis, 2016
8.3.4 What Does the Future Hold for Novartis’ Generic Drugs Business?
8.4 Mylan
8.4.1 Mylan: Historical Financial and Performance Analysis, 2010-2014
8.4.2 Mylan Generic Drugs Sales Forecast 2016-2026
8.4.3 Mylan: Recent Developments
8.4.4 Mylan’s Collaborative Efforts
8.4.5 What Does the Future Hold for Mylan’s Generic Drugs Business?
8.5 Pfizer
8.5.1 Pfizer: Historical Financial and Performance Analysis, 2010-2014
8.5.2 Pfizer’s Restructuring Strategy
8.5.3 Pfizer’s Done Deal with Hospira
8.5.4 Pfizer Generic Drugs Sales Forecast 2016-2026
8.5.5 Hospira: A Brief Overview of Operations
8.5.6 Hospira: Historical Financial and Performance Analysis 2010-2014
8.5.7 Hospira: Recent Developments
8.5.8 Future Prospects for Pfizer’s Generic Business
8.6 Abbott
8.6.1 Abbott: Historical Financial and Performance Analysis, 2010-2014
8.6.2 Abbott Generic Drugs Sales Forecast 2016-2026
8.6.3 Abbott: Recent Developments
8.6.4 What Does the Future Hold for Abbott’s Generic Drugs Business?
8.7 Sun Pharma
8.7.1 Sun Pharma’s Business Areas
8.7.2 Sun Pharma: Historical Financial and Performance Analysis, 2010-2014
8.7.3 Sun Pharma Generic Drugs Sales Forecast 2016-2026
8.7.4 Sun Pharma-Ranbaxy Acquisition
8.8 Aspen
8.8.1 Aspen: Historical Financial and Performance Analysis, 2010-2014
8.8.2 Aspen Generic Sales Forecast 2016-2026
8.8.3 Aspen: Recent Developments
8.8.4 Future Outlook for Aspen’s Generic Business
8.9 Fresenius Kabi
8.9.1 Fresenius Kabi: Historical Financial and Performance Analysis, 2010-2014
8.9.2 Fresenius Kabi Generic Drugs Sales Forecast 2016-2026
8.9.3 InnoPharma Licensing Deal Bolsters Portfolio Grown Via Past Acquisitions
8.9.4 Fresenius Kabi’s Joint Venture with PT Soho Global Health
8.9.5 Future Prospects for Fresenius Kabi’s Generics Business
8.10 Sanofi
8.10.1 Sanofi: Historical Financial and Performance Analysis, 2010-2014
8.10.2 Sanofi Generic Sales Forecast 2016-2026
8.10.3 Sanofi’s Response to Lantus Competition
8.10.4 Sanofi’s Strategies to Develop Generic Sales
8.10.5 Future Prospects for Sanofi’s Generics Business
9. Qualitative Analysis of the Generic Drugs Market, 2016-2026
9.1 Market Factors Influencing the Global Generic Drugs Market
9.2 SWOT Analysis of the Global Generic Drugs Market, 2016-2026
9.2.1 Strengths
9.2.2 Weaknesses
9.2.3 Opportunities
9.2.4 Threats
9.3 Porter’s Five Force Analysis of the Global Generic Drugs Market, 2016-2026
9.3.1 Power of Buyers: Medium
9.3.2 Power of Suppliers: Low
9.3.3 Rivalry among Competitors: High
9.3.4 Threat of New Entrants: High
9.3.5 Threat of Substitutes: Low
10. Conclusions
10.1 Overview of Current Market Conditions and Market Forecast, 2016-2026
10.2 Generic Drugs as a Strategic Tool in Healthcare
10.3 Major Drivers of Growth for Generic Drugs, 2016-2026
10.4 The Regulatory Landscape for Generic Drugs
10.5 Leading Generic Drug Manufacturers
10.6 Future Outlook for the Leading Regions within the Global Generic Drugs Market, 2016-2026
10.7 Generic Penetration by Volume in Leading National Markets
10.8 What Does The Future Hold For The Global Generic Drugs Market?
11. Glossary
【レポート販売概要】
■ タイトル：ジェネリック医薬品の世界市場予測2016-2026■ 英文：Generic Drugs Market Forecast 2016-2026
■ 発行日：2016年4月
■ 調査会社：visiongain
■ 商品コード：VGAIN60631
■ 調査対象地域：グローバル
- オンライン・オンデマンド・ホーム・サービスの世界市場About Online On-demand Home Services On-demand services encompass all digitally based marketplaces (primarily mobile) that offer convenient access to and/or fulfillment of goods and services. The most popular online home services include home cleaning, pest control, laundry services, appliances repair, fitness, beauty, plumbing, electrical, painting, carpentry, beauty, mobile repair, and computer …
- Tesoro Corporation：石油・ガスバリューチェーン分析レポート2013Tesoro Corporation Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Tesoro Corporation" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Tesoro Corporation”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report examines t …
- ブラジル/ロシア/インド/中国の電気生理学（Electrophysiology）市場動向（～2020）BRIC Electrophysiology Market Outlook to 2020 Summary GlobalData’s new report, "BRIC Electrophysiology Market Outlook to 2020", provides key market data on the BRIC Electrophysiology market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Electrophysiology Diagnostic Catheters, Electrophysiology Ablation …
- アドバンストセラミックスの世界市場予測（～2021年）：一体型セラミックス、セラミックコーティング、セラミックス基複合材料“Increasing use of advanced ceramics as an alternative to metals and plastics, and their rising demand in the medical industry are expected to drive the advanced ceramics market” The advanced ceramics market is projected to reach USD 10.41 billion by 2021, at a CAGR of 6.5% during the forecast period. The growth of the advanced ceramics market can be attributed to the increasing use of these ceram …
- 世界のアウトドア服市場動向“Outdoor is a metaphor for freedom, adventure, adrenalin, extraversion, creativity, dynamism, and personal power.” Mike Lipkin, president of Lipkin/Environics Report extract: Outdoor brands have benefitted from the overall casualisation of apparel, while maintaining a “cool” factor based on an implied lifestyle of adventure, leisure, and sport. The pricing of high-end technical apparel makes these …
- 油圧ホース・金具の世界市場2017-2021About Hydraulic Hoses and Fittings In some hydraulic systems, rigid and inflexible tube or pipes are used to transmit energy that is produced by hydraulic fluid to complete the hydraulic circuit. Tubes and pipes can be rigid if there is a requirement to bridge a small amount of space. However, in a majority of applications, there is a need for flexibility and faster transmission of the hydraulic f …
- Sarcoidosis：グローバル臨床試験レビューH2, 2013Sarcoidosis Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Sarcoidosis Global Clinical Trials Review, H2, 2013" provides data on the Sarcoidosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Sarcoidosis. It includes an overview of the trial numbers and their recruitment status as per the site of …
- 短波赤外線（SWIR）の世界市場予測（～2024年）Increasing demand for shortwave infrared (SWIR) products for monitoring & inspection application driving market growthThe SWIR market is expected to grow at a CAGR of 9.87% from 2018 to 2024, to reach USD 258 million by 2024 from USD 147 million in 2018. Rising demand for SWIR cameras for quality control is among the major factors accelerating the growth of the SWIR market for the monitoring and i …
- エレクトリック・ギターの世界市場2016-2020About Electric Guitar An electric guitar is built with a transducer to magnify vibrations of the guitar strings. When the guitar is plugged into an amplifier, the electrical signals generated are boosted by an audio-frequency amplifier and sent to a loudspeaker. The volume and resonance of the guitar are controlled by the player. Special effects such as reverb and distortion can also be generated …
- 世界の次世代シーケンシング(NGS)市場：プラットフォーム、バイオインフォマティクス、技術、用途The global next generation sequencing market is dynamic and witnessing many changes with new products being introduced. The global NGS market will be worth $2.5 billion in 2014 and is poised to reach $8.7 billion by 2020. The NGS market segments such as pre-sequencing products and services, NGS platforms, sequencing services and data analysis/bioinformatics are rapidly growing markets. The overall …
- 世界無線通信会議2015At the WRC-15 in November 2015, decisions are to be taken in one month on three major items: IMT/4G, Broadband PPDR and satellite. A number of bands below 6 GHz are candidates for IMT technologies in Europe including the 700 MHz band. In Europe, a minimum of 2x10 MHz is requested for Broadband PPDR. Channelling of the 700 MHz band is still being debated. This report presents the major WRC-15 agend …
- Venous Leg Ulcers (Crural ulcer)：グローバル臨床試験レビューH2, 2013Venous Leg Ulcers (Crural ulcer) Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Venous Leg Ulcers (Crural ulcer) Global Clinical Trials Review, H2, 2013" provides data on the Venous Leg Ulcers (Crural ulcer) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Venous Leg Ulcers (Crural ulcer). It inclu …
- 自動車用燃料デリバリーシステムの世界市場展望2017-2026According to Stratistics MRC, the Global Automotive Fuel Delivery System Market is accounted for $14.86 billion in 2017 and is expected to reach $27.18 billion by 2026 growing at a CAGR of 6.9%. Rising sales of passenger cars globally, penetration of new fuels and technological advancements are some of the key driving factors for the market growth. However, the efficient and sophisticated fuel del …
- 電力用変圧器の世界市場：市場規模、市場シェア、主要国分析Power Transformers Market, Update 2015 - Global Market Size, Equipment Market Share and Key Country Analysis to 2020 Summary “Power Transformers Market, Update 2015 - Global Market Size, Equipment Market Share and Key Country Analysis to 2020” is the latest market analysis report from GlobalData, the industry analysis specialists that offer comprehensive information and understanding of the power …
- コンプレッサーオイルの世界市場：容積式コンプレッサー、ダイナミックコンプレッサー、合成オイル、半合成オイル、ミネラルオイル、バイオベースオイルThe global compressor oil market is projected to reach USD 83.97 billion by 2021, registering a CAGR of 6.1% between 2016 and 2021. The rapid growth in the end-use industries in Asia-Pacific is a key driver of the compressor oil market. The manufacturing industry consumed more than 35% of compressor oil in 2015.In addition, the rapid growth of various manufacturing industries in emerging nations i …
